Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis

American Journal of Rhinology

Volumn 19, Issue 1, 2005, Pages 65-70

  Folz, Benedikt J ^a   Wollstein, Ana Cerra ^a   Lippert, Burkard M ^a   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUTERIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPY; EPISTAXIS; FEMALE; HUMAN; MALE; NEODYMIUM LASER; NOSE CAVITY; NOSE SEPTUM PERFORATION; PHENOTYPE; RENDU OSLER WEBER DISEASE; SEX DIFFERENCE; SYMPTOMATOLOGY;

EID: 15944378213     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240501900111     Document Type: Article

References (19)

1. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene of hereditary hemorrhagic telangiectasia type 1. Nat Genet 8:345-351, 1994.
2. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 13:189-195, 1996.
3. Caselitz M, Chavan A, Manns MP, et al. Die hereditäre hämorrhagische telangiektasie (Morbus Osler-Rendu-Weber) und ihre manifestation an der leber. Z Gastroenterol 39:533-542, 2001.
4. Folz BJ, Cerra Wollstein A, Alfke H, et al. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: A diagnostic study. Eur Arch Otorhinolaryngol 261:509-516, 2004.
5. Porteus MEM, Burn J, and Proctor SJ. Hereditary haemorrhagic telangiectasia: A clinical analysis. J Med Genet 29:527-530, 1992.
6. Bellusi L, Ferrara Gorga A, Mezzedimi C, et al. A new method for endoscopic evaluation in rhinology: Videocapture. Rhinology 38:13-16, 2000.
7. Plauchu H, de Chadarevian P, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32: 291-297, 1989.
8. Pasche B, Cerra Wollstein A, Zoll B, et al. Rendu-Osler-Weber-syndrome. Dtsch Arztbl 100:A490-A493, 2003.
9. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66-67, 2000.
10. Guttmacher AE, Marchuck DA, and White RI Jr. Hereditary haemorrhagic telangiectasia. N Engl J Med 333:918-924, 1995.
11. Werner JA, Lippert BM, Geisthoff UW, et al. Nd:YAG-lasertherapie der rezidivierenden epistaxis bei hereditärer hämorhagischer telangiektasie. Laryngorhinootologie 76:495-501, 1997.
12. Römer W, Burk M, and Schneider W. Hereditäre hämorrhagische teleangiektasie (Morbus Osler). Dtsch Med Wochenschr 117:669-675, 1992.
13. Mlynski G, Grützenmacher S, Plontke S, et al. Correlation of nasal morphology and respiratory function. Rhinology 39:197-201, 2001.
14. Fischer M, Dietrich U, Labisch C, et al. Kritische Beurteilung der Gefäßembolisation bei Morbus Rendu-Osler. Laryngorhinootologie 76:490-494, 1997.
15. Haitjema T, Balder W, Disch FJ, et al. Epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 34:176-178, 1996.
16. Saunders WH. Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforation. Trans Am Acad Ophthalmol Otolaryngol 64:500-506, 1960.
17. Shapshay SM, and Oliver P. Treatment of hereditary hemorrhagic telangiectasia bei Nd:YAG laser coagulation. Laryngoscope 94:1554-1556, 1984.
18. Stecker RH, and Lake CF. Hereditary hemorrhagic telangiectasia. Arch Otolaryngol 82:522-526, 1965.
19. Ulsø, Vase P, and Stocksted P. Long-term results of dermoplasty in the treatment of hereditary haemorrhagic telangiectasia. J Laryngol Otol 97:223-226, 1983.